-
1
-
-
34548446804
-
Does erythropoietin have a dark side? Epo signaling and cancer cells
-
A.J. Sytkowski Does erythropoietin have a dark side? Epo signaling and cancer cells Sci. STKE 395 2007 pe38
-
(2007)
Sci. STKE
, vol.395
, pp. 38
-
-
Sytkowski, A.J.1
-
3
-
-
66349131929
-
Telomerase structure paves the way for new cancer therapies
-
E. Skordalakes Telomerase structure paves the way for new cancer therapies Future Oncol. 5 2009 163 167
-
(2009)
Future Oncol.
, vol.5
, pp. 163-167
-
-
Skordalakes, E.1
-
4
-
-
35548981401
-
Human telomerase is regulated by erythropoietin and transforming growth factor-beta in human erythroid progenitor cells
-
N. Prade-Houdellier, E. Frébet, and C. Demur et al. Human telomerase is regulated by erythropoietin and transforming growth factor-beta in human erythroid progenitor cells Leukemia 21 2007 2304 2310
-
(2007)
Leukemia
, vol.21
, pp. 2304-2310
-
-
Prade-Houdellier, N.1
Frébet, E.2
Demur, C.3
-
5
-
-
79952100076
-
Erythropoietin activates telomerase through transcriptional and posttranscriptional regulation in human erythroleukemic JAS-REN-A cells
-
M. Akiyama, T. Kawano, and Y. Mikami-Terao et al. Erythropoietin activates telomerase through transcriptional and posttranscriptional regulation in human erythroleukemic JAS-REN-A cells Leuk. Res. 35 2011 416 418
-
(2011)
Leuk. Res.
, vol.35
, pp. 416-418
-
-
Akiyama, M.1
Kawano, T.2
Mikami-Terao, Y.3
-
6
-
-
0034175814
-
Cell cycle restriction of telomere elongation
-
S. Marcand, V. Brevet, and C. Mann et al. Cell cycle restriction of telomere elongation Curr. Biol. 10 2000 487 490
-
(2000)
Curr. Biol.
, vol.10
, pp. 487-490
-
-
Marcand, S.1
Brevet, V.2
Mann, C.3
-
7
-
-
77949352905
-
Telomere shortening sensitizes cancer cells to selected cytotoxic agents: In vitro and in vivo studies and putative mechanisms
-
O. Uziel, E. Beery, and V. Dronichev et al. Telomere shortening sensitizes cancer cells to selected cytotoxic agents: in vitro and in vivo studies and putative mechanisms PLoS ONE 5 2010 e9132
-
(2010)
PLoS ONE
, vol.5
, pp. 9132
-
-
Uziel, O.1
Beery, E.2
Dronichev, V.3
-
8
-
-
84877098846
-
Methylation of the hTERT promoter: A novel cancer biomarker for leptomeningeal metastasis detection in cerebrospinal fluids
-
S. Bougel, B. Lhermitte, and G. Gallagher et al. Methylation of the hTERT promoter: a novel cancer biomarker for leptomeningeal metastasis detection in cerebrospinal fluids Clin. Cancer Res. 19 2013 2216 2223
-
(2013)
Clin. Cancer Res.
, vol.19
, pp. 2216-2223
-
-
Bougel, S.1
Lhermitte, B.2
Gallagher, G.3
-
9
-
-
29244482539
-
Erythropoietin receptor signal transduction requires protein geranylgeranylation
-
N. Sumaya, H. Hamadmad, and K. Matthew Erythropoietin receptor signal transduction requires protein geranylgeranylation J. Pharmacol. Exp. Ther. 316 2006 403 409
-
(2006)
J. Pharmacol. Exp. Ther.
, vol.316
, pp. 403-409
-
-
Sumaya, N.1
Hamadmad, H.2
Matthew, K.3
-
10
-
-
0025123918
-
Erythropoietin receptor. Subunit structure and activation
-
A.D. D'Andrea, and L.I. Zon Erythropoietin receptor. Subunit structure and activation J. Clin. Invest. 86 1990 681 687
-
(1990)
J. Clin. Invest.
, vol.86
, pp. 681-687
-
-
D'Andrea, A.D.1
Zon, L.I.2
-
11
-
-
0028845212
-
Cytokine receptor signaling
-
J.N. Ihle Cytokine receptor signaling Nature 19 1995 591 594
-
(1995)
Nature
, vol.19
, pp. 591-594
-
-
Ihle, J.N.1
-
12
-
-
0031581071
-
Erythropoietin and IL-3 induce tyrosine phosphorylation of CrkL and its association with Shc, SHP-2, and Cbl in hematopoietic cells
-
H. Chin, T. Saito, and A. Arai et al. Erythropoietin and IL-3 induce tyrosine phosphorylation of CrkL and its association with Shc, SHP-2, and Cbl in hematopoietic cells Biochem. Biophys. Res. Commun. 239 1997 412 417
-
(1997)
Biochem. Biophys. Res. Commun.
, vol.239
, pp. 412-417
-
-
Chin, H.1
Saito, T.2
Arai, A.3
-
13
-
-
77953691205
-
The role of erythropoietin and its receptor in growth, survival and therapeutic response of human tumor cells from clinic to bench - A critical review
-
J. Szenajch, G. Wcislo, J.Y. Jeong, C. Szczylik, and L. Feldman The role of erythropoietin and its receptor in growth, survival and therapeutic response of human tumor cells from clinic to bench - a critical review Biochim. Biophys. Acta 2010 1806 82 95
-
(1806)
Biochim. Biophys. Acta
, vol.2010
, pp. 82-95
-
-
Szenajch, J.1
Wcislo, G.2
Jeong, J.Y.3
Szczylik, C.4
Feldman, L.5
|